Event Details
The Nomination Remuneration Committee of Zensar Technologies Limited approved the grant of 6,28,502 (Six lakh twenty eight thousand five hundred and two) options to eligible employees under the 'Zensar - Employees Stock Option Scheme 2025 ('ESOP 2025')'.
Committee Meeting Details
The Nomination and Remuneration Committee meeting was held on July 20, 2026, commencing at 06:00 pm (IST) and concluding at 07:12 pm (IST).
Grant Specifications
- Number of Options Granted: 6,28,502
- Exercise Price: ₹2 per option (face value of shares)
- Total Shares Covered: 6,28,502 equity shares of face value ₹2 each
- Scheme Compliance: In terms of SEBI (SBEB & SE) Regulations, 2021
Exercise Terms
After vesting, options may be exercised (wholly or partially) within a maximum period of 5 (five) years from the date of respective vesting.
Scheme Mechanics
The scheme is administered by the Nomination and Remuneration Committee and implemented through the trust route. The Zensar Employees Welfare Trust shall acquire existing shares by way of secondary acquisition from the market.
Rationale
The exercise price is set at the face value of the shares to align the interests of employees across levels with the performance of the Company and its unlisted subsidiary companies, ensuring upside if backed by individual and company performance.
Not Applicable Sections
The disclosure confirms that the following sections are not applicable as this is solely regarding the grant of options: Options Vested, Options Exercised, Money Realized by Exercise, Total Shares from Exercise, Options Lapsed, Variation in Terms, Subsequent Changes/Cancellation/Exercise, and Diluted EPS impact.